 2 

   	 
       
      ! " #   
$ % &
' ( )  pentobarbital * +  
 ! , - # ./   
0     
1
2  3 4 5 6 7 8 9 :;< = >  ? @ A= > B (SAP)
CD A= > B (MSAP)E
 F G(HR)H = > B ICD = > B J KL M N O = &
 P Q (NA) R S T U V W@
 5 
X @ Y Z L-Glu
     [ NMDA\ non-NMDA:]A1    

^ [X @ Y Z ionotropic glutamate:]A_ ` W kynurenate ab cd e X @ Y Z
kynurenate; NAf
g0  = > B h O i j k 
Y Z gl W@ m kynurenate (0.1, 
0.2, 0.4E 0.8nmol)n
0o p [ 1nmol q r s1     j l  5 Y Z gl
W@ NMDA :]A_ ` W AP-5 (1, 2, 4E 8nmolet
uvo p [ 1nmol q r s1  
  :N Y Z gl W@ w x w yNMDA :]A_ ` W CNQX (0.1, 0.2, 0.4E 0.8nmolet

uvo p [ 1nmol q r s1     z { uvM | 
}~   !  R 
ionotropic glutamate:]Ai   
  NAo   F GR         
l f b  
NA R :]A  NMDA:]A
  non-NMDA:]A


   P Q    q r s:]A       	
        :]A          	
     
   :]A   






















 4 
k     = #  
   h  B  
   A´ ¿ ÀG Õ  
    ­   

 ]   © ! " = # # $ %  
Ø "& ' &
1 ( $ Ô ) « 5 
* z { j H  + , 

 - . /  0 1 [mê ( )  2 3 
z { 4 î 5 6    
K %    ð Éñ 
  7 µ 7 [Hsieh et al., 1988]
) 8   k    7 Ó  
 9 É   = # K
j l \ :  9   
a ; 
  2 3  
Â   < k   = # c 
 b    ionotropic q r s:]AÇ =
KNMDAI non-NMDA :]A 1998>f  ?  P Q (NA) R   þ @ K NMDA
I non-NMDA® ":]A[Neff et al, 1998]agl   = #  
©:]A A   B
"CA É  = # K B D E \j  9 1
z { < k ¾   P Q R F[q r s  m
   :]A  NMDA\ non-NMDA :]A G   0 1  

  " # 
' c 
 1   m= # ­÷ H  §Ocadia sinensis 
¨g¬ I 
A 	 J ­ 1.0 K L ~1.7
K L  M N 
 N Ã  O -10~0Pm Q R S ´ J T U ¬ V 
  © W X  * + Î v:N 

Ã © Y $  Z K [ \ ]  O \ ^ ´ 
 _ ` a R 
 b c   d &./ 6 7  e 8 
¬ I ª f 6
4 g h m< i > 7 h < = > 7 I Y Æ j 7 ¥ 7  k l m n §Sodium pentobarbital, 
15~25mg/kg¨./ i > Y Z * + §c 
  c o p q 1.25mg/hr ¨* + n
 r s t Z = #
AR 
 ©A d u c  J 2vPw g x ; Y Æ j 7 ¥ 7 R 9 : y z { | Ê (respirator, Harvard 
model-665t
l f   · } i ~   Ê ïSpegas, model 321-ETS-100t
 7 { j  · } i ~ 
 ïexpiratory end-tidal CO2 concentrationt
  = # m { j  · } i ~   u c  3.5~5
   7 Ó    
[ g h < = > 7 9 :  B ü   Ê §Pressure transducer, Gould P231D 
¨
Ä 9 :     ó Ê §Electrostatic recorder, Gould ES 1000 
¨¬ I }~B ü  Á í ¯ Ê
§Pressure Processor, Gould 13-4615-52 ó¨  = >  B (Systemic Artery Pressure, SAP)
x ^ [
Ø ¹ º ,   ±  í ¯ Ê §Universal, Gould 13-4615-58 ¨  $ ó  CD  B §Mean Systolic 
Artery Pressure, MSAP)
I,   Ò #   Ê (Biotack, Gould 13-4615-66)
  $   G
§Heart Rate, HR 
¨  Ç È   ð   
Ã    A  ¾  R    ÷ n
Ã  m   §Occipital¨I  ¬   §Parietal¨
      á 
   ®   Û
  ;   ½   ¡  ö ¢ R  
 x K £  7
¤ ¥ a/ 
¬ I  ¦ § u ¨ ê n· ë 
Ä   e 8  Û
ª në 1 ¨  § 
   ¥ n © 

ª      Æ  « ¬ §Aaron, Cautery AA90¨Ã  ½ É ­  9 :  m  7 « ® ¯ u
o
p °  
 ±     ¬² ³ ´  µ T  ¶ §· ventricle¨ ¸ ¹ §Obex¨m º  ­ » ¼
§Stereotaxic zero 
¨ ½   A  ¾  ¾ $ j k m ¿ À 
./ i Â   c 
  
Kynurenic acid(Kyn)  " L Á Â ç     Ã Ä s(excitatory amino acid, EAA) 
_ ` W(antagonistt[Zhang and Mifflin, 1995 ]­ñ b    R NA:]A 9 
 ionotropic q r s:]A
gl W@ m kynurenic aciÅ
¬ I ­ 0.1, 0.2, 0.4 I 0.8 nmol

X @ Y Z    NA   R a ; ¬ I Y Z Kynmê IY Z  30¬ V E 60¬ V n
 6 
Ä G ­ñ b    R NA :]A 9   NMDA :]A1z { 2   
NMDA :]A_ ` W AP-5./ Y Z è 2A­W@ ­ 8 nmolm AP-5
./ X @ Y Z
   NA   R Fa ; ¬ I Y Z AP-5mê IY Z 20h60¬ V nÄ X @ Y Z q r
sFl  ¾ O 1 ó Ò   B   è© 1¬ I ¿ º = > B hCD = > B I
F Gó  z { ô  ó    
AP-5 k   F GO i @ m % õ  
© uv õ è 2B º 1| ö© ¤ ¿ À ¿ º q r s1    O i @ 
 Ý ¿ À
¬ I ¿ º AP-5gl W@ / (1, 2, 4,E 8nmol)[è 2AI 2BM | z {   ;
 AP-5
W@ 4nmol Y Z n 20¬ V Ä Y Z q r sf
 ø 0KÙ ù      
aY Z n 60¬
V Ä Y Z q r s
©   ø ú û ñ ã Ø z { b    R NA :]A 
NMDA :]Aj l 
©Ù ù Î v ÷ W@ U V aU ¯ 
a ; U V W@ ; 8nmolf

©Ù  Î v A  + 
Ä G ­ñ b    R NA:]A 9   non-NMDA :]A
12  
non-NMDA :]A_ ` W CNQX
./ Y Z è 3A­W@ ­ 0.8 nmolm CNQX
.
/ X @ Y Z    NA   R Fa ; ¬ I Y Z  CNQXmê IY Z 20h60¬ V n
Ä X @ Y Z q r sFl  ¾ O 1 ó Ò   B   è© 1¬ I ¿ º = > B hC
D = > B I F Gó  © uv õ è 3Bö© ¤ ¿ À ¿ º q r s1  
 O i @ 
 Ý ¿ À ¬ I ¿ º CNQXgl W@ / (0.1, 0.2, 0.4E 0.8nmol)[è 3AI
3B º M | z {   ;
 CNQXW@ 0.4nmol Y Z n 20¬ V Ä Y Z q r sf
 ø 0K
Ù ù      aY Z n 60¬ V Ä Y Z q r s
©   ø S  ú û ñ 1
z {  b    R NA:]A  non-NMDA :]A Ø m
©Ù ù 
Î v ÷ W@ U V aU ¯ 
W@ U V ; 0.8nmol f  
©Ù ù Î v  + 
[z { c 
 uvb  F  R DMV/NA
[q r s     :
]A  ionotropic q r s:]A; ©  ¼ ¾ O [ Ù Ú è 4 R  | M |   l fF
z {  b  
  R DMV/NA
[q r s     :]A ñ = K NMDA 
:]A
 Ç = K non-NMDA :]AØ uvÉ 1998> NeffèÂ   $   = #  NA
R Ç = K NMDAI non-NMDA :]Aj 	 Ï [Neff et al, 1998]

) * + , 
Bliss, T.V.P. and Collingridge, G.L. A synaptic model of memory: long-term potentiation in the 
hippocampus. Nature. 361: 31-39, 1993. 
Collingridge, G.L., Watkins, J.C. The NMDA ReceptorCollingride, G.L., Watkins, J.C., eds
2nd ed., pp 1-103, 1994. 
Cotman, C.W. and Iversen, L.L. Excitatory amino acid in the brain: focus on NMDA receptors. 
Trends Neurosci. 10: 263-265, 1987. 
Donevan, S.D. and Rogawski, M.A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, 
neuroprotective antagonist of AMPA/kainite receptor reponses. Neuron.  10:51-59, 1993. 
 8 

                           
     è 1AhW@ ­ 0.4 nmolm kynurenic acid
./ X @ Y Z    NA   R 

a ; ¬ I Y Z Kynmê IY Z 30h60¬ V nÄ X @ Y Z q r s
l  ¾ O 1 ó Ò
  B   è
 
 
   
è 1Bhionotropic q r s:]A_ ` W Kyn./ NA¾ O Y Z 
1  uv¡ 
èº © ¤ ¿ À ¿ º q r s1    O i @ 
Ý ¿ À ¬ I ¿ º Kyngl W
@ / (0.1, 0.2, 0.4E 0.8 nmole)[èº M | z {   ;
 KynW@ 0.2nmolY Z n
30¬ V Ä Y Z q r sf
ø 0KÙ ù      
aY Z n 60¬ V Ä Y Z q r s

©   ø ú û ñ 
 
 
L-Glu L-Glu L-Glu 
40 
10 
SAP 
(mmHg) 
10 
40 
MSAP 
(mmHg) 
0 
50 
HR 
(bpm) 
30 min After 60 min After Before KYN 
1 min 
 10 
 
                         
   è 3AhW@ ­ 
  8 nmolm CNQX
./ X @ Y Z    NA   R 
a ; ¬ I
Y Z  CNQXmê IY Z 20h60¬ V nÄ X @ Y Z q r s
l  ¾ O 1 ó Ò   B
  è
 
 
è 3Bhw x w yNMDA :]A_ ` W CNQX./ NA¾ O Y Z 
1  uv¡  èº 
© ¤ ¿ À ¿ º q r s1    O i @ 
 Ý ¿ À ¬ I ¿ º  CNQXgl W@ /
(0.1, 0.2, 0.4E 
  8 nmole)[èº M | z {   ;
 CNQXW@ 0.8nmolY Z n 20
¬ V Ä Y Z q r sf
ø 0KÙ ù      
aY Z n 60¬ V Ä Y Z q r s
©
  ø ú û ñ 

40 
10 
SAP 
(mmHg) 
10 
40 
MSAP 
(mmHg) 
0 
50 
HR 
(bpm) 
20 min After 60 min After Before CNQX 
L-Glu L-Glu L-Glu 
1 min 
